Novacyt S.A.—Sch1 from the international diagnostics group, generating revenues from the sale of clinical products used in oncology, microbiology, haematology and serology testing. Offer to raise £8.8m at 59.38p with a value of £22.4m. Expected 01 Nov.
Footasylum Ltd—UK-based fashion retailer focusing on the branded footwear and apparel markets announced its intention to seek admission to AIM. Expected value between £130m and £150m. Due Nov 2017.
Totally (TLY) - Sch 1 for £11m RTO of Vocare, a ....
18 Oct 2017
Small Cap Breaskfast
Oncimmune Holdings Plc (ONC:LON), 18.0 | IQGeo Group PLC (IQG:LON), 381 | Be Heard Group (BHRD:LON), 0 | Proteome Sciences plc (PRM:LON), 0 | SIMEC Atlantis Energy Ltd. (SAE:LON), 0.8 | FireAngel Safety Technology Group plc (FA:LON), 5.5 | Tissue Regenix Group plc (TRX:LON), 68.0 | Barryroe Offshore Energy PLC (PVDRF:OTC), 0
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Small Cap Breaskfast
Oncimmune Holdings Plc (ONC:LON), 18.0 | IQGeo Group PLC (IQG:LON), 381 | Be Heard Group (BHRD:LON), 0 | Proteome Sciences plc (PRM:LON), 0 | SIMEC Atlantis Energy Ltd. (SAE:LON), 0.8 | FireAngel Safety Technology Group plc (FA:LON), 5.5 | Tissue Regenix Group plc (TRX:LON), 68.0 | Barryroe Offshore Energy PLC (PVDRF:OTC), 0
- Published:
18 Oct 2017 -
Author:
Derren Nathan - Pages:
Novacyt S.A.—Sch1 from the international diagnostics group, generating revenues from the sale of clinical products used in oncology, microbiology, haematology and serology testing. Offer to raise £8.8m at 59.38p with a value of £22.4m. Expected 01 Nov.
Footasylum Ltd—UK-based fashion retailer focusing on the branded footwear and apparel markets announced its intention to seek admission to AIM. Expected value between £130m and £150m. Due Nov 2017.
Totally (TLY) - Sch 1 for £11m RTO of Vocare, a ....